Evaluation and Limitations of the Novel Chemiluminescent Enzyme Immunoassay Technique for Measuring Total Tau Protein in the Cerebrospinal Fluid of Patients with Human Prion Disease: A 10-Year Prospective Study (2011–2020)

Evaluation and Limitations of the Novel Chemiluminescent Enzyme Immunoassay Technique for Measuring Total Tau Protein in the Cerebrospinal Fluid of Patients with Human Prion Disease: A 10-Year Prospective Study (2011–2020)

Background: Recently, the investigation of cerebrospinal fluid (CSF) biomarkers for diagnosing human prion diseases (HPD) has garnered significant attention. Reproducibility and accuracy are paramount in biomarker research, particularly in the measurement of total tau (T-tau) protein, which is a cru...

Full description

Bibliographic Details
Main Authors: Kong Weijie, Toshiaki Nonaka, Katsuya Satoh
Format: Article
Language:English
Published: MDPI AG 2024-07-01
Series:Diagnostics
Subjects:
cerebrospinal fluid
Creutzfeldt–Jakob disease
diagnostic test
prion protein
chemiluminescent enzyme immunoassay
human prion disease
Online Access:https://www.mdpi.com/2075-4418/14/14/1520

Internet

https://www.mdpi.com/2075-4418/14/14/1520

Similar Items